financetom
Business
financetom
/
Business
/
Casino Operator MGM beats first-quarter estimates on strength in Macau business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Casino Operator MGM beats first-quarter estimates on strength in Macau business
May 1, 2024 4:03 PM

(Reuters) - MGM Resorts International ( MGM ) beat first-quarter Wall Street estimates on Wednesday, driven by strength in its China operations as the casino operator continues to benefit from easing post-pandemic entry restrictions.

Shares of the company were up about 3.14% in extended trading.

Casino operators such as MGM and Wynn have benefited from the surge in traffic at their gaming hubs in Macau after a resurgence of travel and tourism spending in the world's second-largest economy.

Adjusted property EBITDAR for MGM China was 78% higher in the first quarter compared with last year.

" We achieved record results in the first quarter of 2024 driven by strong performance at MGM China and in Las Vegas specifically at our luxury resort properties," CEO Bill Hornbuckle said in a statement.

The company also said that regional operations in the U.S. were impacted by poor winter weather in January followed by a quick recovery in February and acceleration into March.

Earlier this week, casino giant Caesars Entertainment also flagged a hit from weather conditions in January and February which battered its first-quarter results.

"In the longer term, we have an enviable pipeline of limited license development projects in New York, Japan and potentially the United Arab Emirates which will drive free cash flow growth over the next decade," said CFO Jonathan Halkyard in a post-earnings call.

MGM's total revenue jumped 13% to $4.38 billion in the quarter through March, above analysts' estimate of $4.24 billion, according to LSEG data.

Its quarterly adjusted profit per share of 74 cents also came ahead of Wall Street expectations of 56 cents.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SpringWorks Therapeutics Insider Sold Shares Worth $2,558,237, According to a Recent SEC Filing
SpringWorks Therapeutics Insider Sold Shares Worth $2,558,237, According to a Recent SEC Filing
Feb 13, 2025
04:12 AM EST, 02/13/2025 (MT Newswires) -- Saqib Islam, Director, Chief Executive Officer, on February 10, 2025, sold 48,000 shares in SpringWorks Therapeutics ( SWTX ) for $2,558,237. Following the Form 4 filing with the SEC, Islam has control over a total of 1,002,502 common shares of the company, with 1,002,502 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465925012363/xslF345X05/tm256428-3_4seq1.xml ...
Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs
Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs
Feb 13, 2025
04:09 AM EST, 02/13/2025 (MT Newswires) -- Ascendis Pharma ( ASND ) said late Wednesday its board has allocated $25 million to fund a share buyback program and the net settlement of certain restricted stock units, or RSUs. The buyback program authorizes the repurchase from time to time of up to about $18.3 million of American depositary shares. The company...
Super Micro Computer Prices Private Placement of $700 Million in Convertible Senior Notes
Super Micro Computer Prices Private Placement of $700 Million in Convertible Senior Notes
Feb 13, 2025
04:08 AM EST, 02/13/2025 (MT Newswires) -- Super Micro Computer ( SMCI ) said late Wednesday it has priced its private placement of $700 million in 2.25% convertible senior notes due 2028. The company said it also amended pricing terms for its existing private placement of $1.73 billion convertible senior notes due 2029. The amendments and subscription are expected to...
SpringWorks Therapeutics Insider Sold Shares Worth $1,617,329, According to a Recent SEC Filing
SpringWorks Therapeutics Insider Sold Shares Worth $1,617,329, According to a Recent SEC Filing
Feb 13, 2025
04:11 AM EST, 02/13/2025 (MT Newswires) -- Daniel Pichl, Chief People Officer, on February 10, 2025, sold 29,750 shares in SpringWorks Therapeutics ( SWTX ) for $1,617,329. Following the Form 4 filing with the SEC, Pichl has control over a total of 50,762 common shares of the company, with 50,762 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465925012365/xslF345X05/tm256428-5_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved